Share

TG Therapeutics CEO on developing treatments for patients with multiple sclerosis

TG Therapeutics CEO Mike Weiss explained the biopharmaceutical company's plans to address the multiple sclerosis drug market and carve a lane away from competitors in the space.
01:40
Wed, Jan 13 20217:05 PM EST